Close

Analyst Ratings for Obalon Therapeutics (OBLN) [Neutrals]

All Latest Ratings for OBLN

OBLN Rating Summary

  |   Expand Research on OBLN
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5.7 / 10   Percentile Rank: 62%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/8/2019 Canaccord Genuity
» Updated 5/22/2019		 Kyle Rose Downgrade Hold
(Buy)		 1.00
(1.50)		 0.56
(3.05)		 444.64% Details
2/26/2019 Roth/MKM David Solomon Downgrade Neutral
(Buy)		 2.75
(6.00)		 1.96
(3.05)		 55.61% Details